The World Health Organization (WHO) and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) announced a new collaboration to enhance the registry and sharing of regulatory information on medical products globally.
The collaboration will establish a unified language that streamlines worldwide regulatory decision-making regarding the safety and efficacy of medical products by connecting the WHO International Classification of Diseases (ICD-11) with the ICH Medical Dictionary for Regulatory Activities (MedDRA).
The resulting common language will enhance the analysis of scenarios such as insurance claims databases, mortality and morbidity statistics, clinical trials, observational studies, etc. MedDRA is a standardized medical terminology developed by ICH to facilitate sharing of regulatory information internationally for medical products used by humans.
Meanwhile, ICD-11, the International Classification of Diseases, is the global standard for recording, reporting, analyzing, and comparing reasons for illness and death. It helps to identify and prioritize key health issues, enabling the development of effective public health policies by countries.
Click here to read the original article published by World Health Organization (WHO).
Please give your feedback on this article or share a similar story for publishing by clicking here.
